(1 - 15 von 18
)
Positive EB Trial Data Puts Filsuvez on Track for Regulatory ...
epidermolysisbullosanews.com
— ... pediatric disease has been a challenging but enormously important undertaking,” said Mark Sumeray, MD, chief medical officer of Amryt. › ...
POSITIVE TOP LINE RESULTS FROM PHASE 3 TRIAL IN EB
www.globenewswire.com
Dr Mark Sumeray, Chief Medical Officer of Amryt commented: “The ... on the speed of wound healing in such a complex clinical situation.
sortiert nach Relevanz / Datum